{"id":769,"date":"2026-09-21T18:57:32","date_gmt":"2026-09-21T18:57:32","guid":{"rendered":"https:\/\/5mn.ch\/?page_id=769"},"modified":"2026-10-07T12:11:30","modified_gmt":"2026-10-07T12:11:30","slug":"research","status":"publish","type":"page","link":"http:\/\/5mn.ch\/de\/research\/","title":{"rendered":"Research"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"769\" class=\"elementor elementor-769\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e5c5655 e-flex e-con-boxed e-con e-parent\" data-id=\"e5c5655\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b5f8eab elementor-widget elementor-widget-html\" data-id=\"b5f8eab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!-- 5mn Research placeholder, PART 1 of 3 (styles, banner, Switzerland). Company list checked 7 Oct 2026. -->\n<!-- Each company line: <b>name<\/b><i>country<\/i><span>ticker \u00b7 exchange<\/span><em>focus<\/em> -->\n<style>\n.r5{--r5-ink:#1b2036;--r5-muted:#5b6275;--r5-line:#e4e6e0;--r5-green-t:#2f6f4c;color:var(--r5-ink);max-width:1120px;margin:0 auto;font-family:inherit}\n.r5 *{box-sizing:border-box}\n.r5 [hidden]{display:none !important}\n.r5 .r5-hero{position:relative;overflow:hidden;background:#1b2036;color:#fff;border-radius:18px;padding:52px 48px}\n.r5 .r5-hero::before{content:\"\";position:absolute;width:340px;height:340px;border-radius:50%;background:#26304a;right:-90px;top:-110px}\n.r5 .r5-hero::after{content:\"\";position:absolute;width:96px;height:96px;border-radius:50%;background:#a9d8bb;border:26px solid #3b855c;right:110px;top:170px}\n.r5 .r5-hero > *{position:relative;z-index:1}\n.r5 .r5-hero .r5-eyebrow{display:inline-block;margin:0;font-size:12px;font-weight:600;letter-spacing:.14em;text-transform:uppercase;color:#1b2036;background:#d9b26f;padding:5px 10px;border-radius:4px}\n.r5 .r5-hero h2{color:#fff;font-size:clamp(28px,4vw,40px);line-height:1.2;margin:18px 0 16px;max-width:760px}\n.r5 .r5-hero p{color:#d6d9e3;font-size:17px;line-height:1.7;max-width:620px;margin:0 0 12px}\n.r5 .r5-stats{display:flex;flex-wrap:wrap;gap:12px 40px;margin:28px 0 30px;padding:0;list-style:none}\n.r5 .r5-stats li{margin:0;font-size:14px;color:#d6d9e3;line-height:1.4}\n.r5 .r5-stats strong{display:block;font-size:30px;font-weight:600;color:#a9d8bb;line-height:1.2}\n.r5 .r5-btns{display:flex;flex-wrap:wrap;gap:12px}\n.r5 .r5-btn{display:inline-block;padding:13px 24px;border-radius:8px;font-weight:600;font-size:15px;line-height:1.2;text-decoration:none !important}\n.r5 .r5-btn-main{background:#3b855c;color:#fff !important;border:1px solid #3b855c}\n.r5 .r5-btn-main:hover{background:#2f6f4c;border-color:#2f6f4c}\n.r5 .r5-btn-alt{background:transparent;color:#fff !important;border:1px solid rgba(255,255,255,.45)}\n.r5 .r5-btn-alt:hover{border-color:#fff}\n.r5 .r5-list{margin-top:56px}\n.r5 .r5-list h3{margin:0;font-size:28px;line-height:1.25;color:var(--r5-ink)}\n.r5 .r5-list > p{margin:6px 0 0;font-size:15px;color:var(--r5-muted)}\n.r5 .r5-tools{display:none;flex-direction:column;gap:14px;margin-top:20px}\n.r5.r5-js .r5-tools{display:flex}\n.r5 .r5-search{width:320px;max-width:100%;padding:11px 14px;border:1px solid #d5d8d0;border-radius:8px;font:inherit;font-size:15px;color:var(--r5-ink);background:#fff}\n.r5 .r5-search:focus{outline:2px solid #3b855c;outline-offset:1px}\n.r5 .r5-chips{display:flex;flex-wrap:wrap;gap:8px}\n.r5 .r5-chip{font:inherit;font-size:13px;line-height:1.2;padding:7px 14px;border-radius:16px;border:1px solid #d5d8d0;background:#fff;color:var(--r5-ink);cursor:pointer}\n.r5 .r5-chip:hover{border-color:#3b855c}\n.r5 .r5-chip[aria-pressed=\"true\"]{background:#2f6f4c;border-color:#2f6f4c;color:#fff}\n.r5 .r5-group{margin-top:36px}\n.r5 > .r5-group:first-child{margin-top:16px}\n.r5 .r5-group h4{display:flex;flex-wrap:wrap;justify-content:space-between;gap:4px 12px;margin:0 0 16px;padding-bottom:10px;border-bottom:1px solid var(--r5-line);font-size:13px;font-weight:600;letter-spacing:.12em;text-transform:uppercase;color:var(--r5-green-t)}\n.r5 .r5-group h4 span{font-weight:500;letter-spacing:.04em;text-transform:none;color:var(--r5-muted)}\n.r5 .r5-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(250px,1fr));gap:14px;list-style:none;margin:0;padding:0}\n.r5 .r5-co{margin:0;background:#fff;border:1px solid var(--r5-line);border-radius:12px;padding:16px 18px;display:grid;grid-template-columns:1fr auto;gap:6px 10px;align-content:start}\n.r5 .r5-co b{font-weight:600;font-size:16px;line-height:1.3;color:var(--r5-ink)}\n.r5 .r5-co small{display:block;margin-top:2px;font-size:12px;font-weight:400;color:var(--r5-muted)}\n.r5 .r5-co i{align-self:start;font-style:normal;font-size:11px;font-weight:600;letter-spacing:.08em;color:var(--r5-muted);background:#eef0f3;border-radius:4px;padding:2px 6px}\n.r5 .r5-co span{grid-column:1\/-1;font-size:13px;font-weight:500;color:var(--r5-green-t);line-height:1.4}\n.r5 .r5-co em{grid-column:1\/-1;font-style:normal;font-size:14px;line-height:1.5;color:var(--r5-muted)}\n.r5 .r5-empty{margin:32px 0 0;font-size:15px;color:var(--r5-muted)}\n.r5 .r5-note{margin:40px 0 0;padding-top:16px;border-top:1px solid var(--r5-line);font-size:13px;line-height:1.6;color:var(--r5-muted)}\n@media (max-width:767px){\n  .r5 .r5-hero{padding:36px 22px;border-radius:14px}\n  .r5 .r5-hero::before{width:220px;height:220px;right:-90px;top:-90px}\n  .r5 .r5-hero::after{display:none}\n  .r5 .r5-hero p{font-size:16px}\n  .r5 .r5-hero .r5-eyebrow{font-size:11px;letter-spacing:.1em}\n  .r5 .r5-stats{gap:12px 28px}\n  .r5 .r5-btns .r5-btn{flex:1 1 100%;text-align:center}\n  .r5 .r5-list h3{font-size:24px}\n  .r5 .r5-search{width:100%}\n}\n<\/style>\n<div class=\"r5\">\n<section class=\"r5-hero\"><p class=\"r5-eyebrow\">5mn Research \u00b7 Coming soon<\/p><h2>Our first Spotlights are on their way<\/h2><p>Spotlights are condensed, independent research on listed Swiss and European biotech companies, each with its own valuation model. While we prepare the first ones, here are the companies we follow.<\/p><p>Investors and companies are welcome to get in touch: to hear when the first Spotlight is out, to suggest a company, or to talk about coverage.<\/p><ul class=\"r5-stats\"><li><strong>73<\/strong>listed companies<\/li><li><strong>14<\/strong>countries<\/li><li><strong>Daily<\/strong>news in the Daily Brief<\/li><\/ul><div class=\"r5-btns\"><a class=\"r5-btn r5-btn-main\" href=\"\/contact\/\">Contact us<\/a><a class=\"r5-btn r5-btn-alt\" href=\"\/insights\/\">Read the Daily Brief<\/a><\/div><\/section>\n<div class=\"r5-list\"><h3>Companies we follow<\/h3><p>Listed biotech across Europe, plus Swiss medtech and life-science companies, grouped by headquarters.<\/p><div class=\"r5-tools\"><input class=\"r5-search\" type=\"search\" placeholder=\"Search company, ticker or area\" aria-label=\"Search companies\"><div class=\"r5-chips\" role=\"group\" aria-label=\"Filter by region\"><button type=\"button\" class=\"r5-chip\" data-f=\"all\" aria-pressed=\"true\">All<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"ch\" aria-pressed=\"false\">Switzerland<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"benelux\" aria-pressed=\"false\">Benelux<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"fr\" aria-pressed=\"false\">France<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"de\" aria-pressed=\"false\">Germany<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"nordics\" aria-pressed=\"false\">Nordics<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"ukie\" aria-pressed=\"false\">UK &amp; Ireland<\/button><button type=\"button\" class=\"r5-chip\" data-f=\"south\" aria-pressed=\"false\">Southern &amp; Eastern Europe<\/button><\/div><\/div>\n<div class=\"r5-group\" data-group=\"ch\"><h4>Switzerland<span data-total=\"20\" data-sub=\"SIX-listed or Swiss-headquartered \u00b7 biotech &amp; medtech\">20 companies \u00b7 SIX-listed or Swiss-headquartered \u00b7 biotech &amp; medtech<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>AC Immune<\/b><i>CH<\/i><span>ACIU \u00b7 Nasdaq<\/span><em>Neurodegeneration \u00b7 vaccines &amp; antibodies<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>ADC Therapeutics<\/b><i>CH<\/i><span>ADCT \u00b7 NYSE<\/span><em>Oncology \u00b7 Zynlonta (ADC)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Addex Therapeutics<\/b><i>CH<\/i><span>ADXN \u00b7 SIX<\/span><em>Neurology \u00b7 allosteric modulators<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Basilea Pharmaceutica<\/b><i>CH<\/i><span>BSLN \u00b7 SIX<\/span><em>Anti-infectives \u00b7 Cresemba, Zevtera<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>BioVersys<\/b><i>CH<\/i><span>BIOV \u00b7 SIX<\/span><em>Antibacterials \u00b7 BV100, alpibectir<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Ireland\"><b>Cosmo Pharmaceuticals<\/b><i>IE<\/i><span>CMHC \u00b7 SIX<\/span><em>Dermatology &amp; GI \u00b7 clascoterone<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>CRISPR Therapeutics<\/b><i>CH<\/i><span>CRSP \u00b7 Nasdaq<\/span><em>Gene editing \u00b7 Casgevy<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Idorsia<\/b><i>CH<\/i><span>IDIA \u00b7 SIX<\/span><em>Sleep &amp; hypertension \u00b7 Quviviq, Tryvio<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Kuros Biosciences<\/b><i>CH<\/i><span>KURN \u00b7 SIX<\/span><em>Spinal fusion \u00b7 MagnetOs bone graft<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Medacta<\/b><i>CH<\/i><span>MOVE \u00b7 SIX<\/span><em>Orthopaedics \u00b7 hip, knee, shoulder &amp; spine<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Medartis<\/b><i>CH<\/i><span>MED \u00b7 SIX<\/span><em>Bone fixation \u00b7 hand, foot &amp; facial surgery<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Molecular Partners<\/b><i>CH<\/i><span>MOLN \u00b7 SIX, Nasdaq<\/span><em>Oncology \u00b7 radio-DARPins<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>MoonLake Immunotherapeutics<\/b><i>CH<\/i><span>MLTX \u00b7 Nasdaq<\/span><em>Inflammation \u00b7 sonelokimab<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Italy\"><b>Newron Pharmaceuticals<\/b><i>IT<\/i><span>NWRN \u00b7 SIX<\/span><em>Schizophrenia \u00b7 evenamide<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Oculis<\/b><i>CH<\/i><span>OCS \u00b7 Nasdaq<\/span><em>Ophthalmology \u00b7 privosegtor<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Pharvaris<\/b><i>CH<\/i><span>PHVS \u00b7 Nasdaq<\/span><em>Hereditary angioedema \u00b7 deucrictibant<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Santhera Pharmaceuticals<\/b><i>CH<\/i><span>SANN \u00b7 SIX<\/span><em>Duchenne \u00b7 Agamree (vamorolone)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Straumann<\/b><i>CH<\/i><span>STMN \u00b7 SIX<\/span><em>Dentistry \u00b7 implants &amp; clear aligners<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>VERAXA Biotech<\/b><i>CH<\/i><span>VRXA \u00b7 Nasdaq<\/span><em>Oncology \u00b7 T-cell engagers &amp; ADCs<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Switzerland\"><b>Xlife Sciences<\/b><i>CH<\/i><span>XLS \u00b7 SIX<\/span><em>Life-science project incubator<\/em><\/li>\n<\/ul><\/div>\n<\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-66fcd51 e-flex e-con-boxed e-con e-parent\" data-id=\"66fcd51\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-722004f elementor-widget elementor-widget-html\" data-id=\"722004f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!-- 5mn Research placeholder, PART 2 of 3 (Benelux, France, Germany). -->\n<div class=\"r5\">\n<div class=\"r5-group\" data-group=\"benelux\"><h4>Benelux<span data-total=\"7\" data-sub=\"\">7 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"Belgium\"><b>Agomab Therapeutics<\/b><i>BE<\/i><span>AGMB \u00b7 Nasdaq<\/span><em>Fibrosis \u00b7 ontunisertib<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Netherlands\"><b>argenx<\/b><i>NL<\/i><span>ARGX \u00b7 Euronext Brussels, Nasdaq<\/span><em>Immunology \u00b7 Vyvgart (FcRn)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Belgium formerly Galapagos\"><b>Lakefront Biotherapeutics<small>formerly Galapagos<\/small><\/b><i>BE<\/i><span>LKFT \u00b7 Euronext, Nasdaq<\/span><em>Immunology \u00b7 gamgertamig<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Netherlands\"><b>NewAmsterdam Pharma<\/b><i>NL<\/i><span>NAMS \u00b7 Nasdaq<\/span><em>Cardiometabolic \u00b7 obicetrapib<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Netherlands\"><b>Pharming<\/b><i>NL<\/i><span>PHARM \u00b7 Euronext Amsterdam \/ PHAR \u00b7 Nasdaq<\/span><em>Rare diseases \u00b7 Joenja, Ruconest<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Netherlands\"><b>ProQR Therapeutics<\/b><i>NL<\/i><span>PRQR \u00b7 Nasdaq<\/span><em>RNA editing \u00b7 Axiomer<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Netherlands\"><b>uniQure<\/b><i>NL<\/i><span>QURE \u00b7 Nasdaq<\/span><em>Gene therapy \u00b7 AMT-130 (Huntington's)<\/em><\/li>\n<\/ul><\/div>\n<div class=\"r5-group\" data-group=\"fr\"><h4>France<span data-total=\"14\" data-sub=\"\">14 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"France\"><b>Abionyx Pharma<\/b><i>FR<\/i><span>ABNX \u00b7 Euronext Paris<\/span><em>Sepsis &amp; critical care \u00b7 apoA-I platform<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Abivax<\/b><i>FR<\/i><span>ABVX \u00b7 Euronext Paris, Nasdaq<\/span><em>Ulcerative colitis \u00b7 obefazimod<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Adocia<\/b><i>FR<\/i><span>ADOC \u00b7 Euronext Paris<\/span><em>Diabetes \u00b7 BioChaperone formulations<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Cellectis<\/b><i>FR<\/i><span>ALCLS \u00b7 Euronext Growth \/ CLLS \u00b7 Nasdaq<\/span><em>Gene editing \u00b7 allogeneic CAR-T<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>DBV Technologies<\/b><i>FR<\/i><span>DBV \u00b7 Euronext Paris \/ DBVT \u00b7 Nasdaq<\/span><em>Food allergy \u00b7 Viaskin Peanut<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Genfit<\/b><i>FR<\/i><span>GNFT \u00b7 Euronext Paris<\/span><em>Liver diseases \u00b7 ACLF, Iqirvo (Ipsen)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Innate Pharma<\/b><i>FR<\/i><span>IPH \u00b7 Euronext Paris \/ IPHA \u00b7 Nasdaq<\/span><em>Oncology \u00b7 IPH4502 (ADC), NK cell engagers<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Inventiva<\/b><i>FR<\/i><span>IVA \u00b7 Euronext Paris, Nasdaq<\/span><em>MASH \u00b7 lanifibranor<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Medincell<\/b><i>FR<\/i><span>MEDCL \u00b7 Euronext Paris<\/span><em>Long-acting injectables \u00b7 Uzedy (Teva)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Nanobiotix<\/b><i>FR<\/i><span>NANO \u00b7 Euronext Paris \/ NBTX \u00b7 Nasdaq<\/span><em>Oncology \u00b7 JNJ-1900 (NBTXR3)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>OSE Immunotherapeutics<\/b><i>FR<\/i><span>OSE \u00b7 Euronext Paris<\/span><em>Immunology &amp; oncology \u00b7 Tedopi<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Sensorion<\/b><i>FR<\/i><span>ALSEN \u00b7 Euronext Growth<\/span><em>Hearing loss \u00b7 gene therapy SENS-501<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Transgene<\/b><i>FR<\/i><span>TNG \u00b7 Euronext Paris<\/span><em>Cancer vaccines \u00b7 TG4050<\/em><\/li>\n<li class=\"r5-co\" data-k=\"France\"><b>Valneva<\/b><i>FR<\/i><span>VLA \u00b7 Euronext Paris \/ VALN \u00b7 Nasdaq<\/span><em>Vaccines \u00b7 Lyme disease (with Pfizer)<\/em><\/li>\n<\/ul><\/div>\n<div class=\"r5-group\" data-group=\"de\"><h4>Germany<span data-total=\"5\" data-sub=\"\">5 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"Germany\"><b>BioNTech<\/b><i>DE<\/i><span>BNTX \u00b7 Nasdaq<\/span><em>Oncology &amp; vaccines \u00b7 mRNA, pumitamig<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Germany\"><b>Evotec<\/b><i>DE<\/i><span>EVT \u00b7 Frankfurt \/ EVO \u00b7 Nasdaq<\/span><em>Drug discovery &amp; development partner<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Germany\"><b>Formycon<\/b><i>DE<\/i><span>FYB \u00b7 Frankfurt<\/span><em>Biosimilars \u00b7 aflibercept, ustekinumab<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Germany\"><b>Heidelberg Pharma<\/b><i>DE<\/i><span>HPHA \u00b7 Frankfurt<\/span><em>Oncology \u00b7 ATAC antibody-drug conjugates<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Germany\"><b>Immatics<\/b><i>DE<\/i><span>IMTX \u00b7 Nasdaq<\/span><em>Oncology \u00b7 TCR-T anzu-cel (IMA203)<\/em><\/li>\n<\/ul><\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-71993d1 e-flex e-con-boxed e-con e-parent\" data-id=\"71993d1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-90c6ccc elementor-widget elementor-widget-html\" data-id=\"90c6ccc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!-- 5mn Research placeholder, PART 3 of 3 (Nordics, UK & Ireland, Southern & Eastern Europe, note, search script). -->\n<div class=\"r5\">\n<div class=\"r5-group\" data-group=\"nordics\"><h4>Nordics<span data-total=\"15\" data-sub=\"\">15 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"Iceland\"><b>Alvotech<\/b><i>IS<\/i><span>ALVO \u00b7 Nasdaq Iceland, Nasdaq<\/span><em>Biosimilars \u00b7 Simlandi<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Denmark\"><b>Ascendis Pharma<\/b><i>DK<\/i><span>ASND \u00b7 Nasdaq<\/span><em>Endocrinology \u00b7 TransCon (Yorvipath, Yuviwel)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Denmark\"><b>Bavarian Nordic<\/b><i>DK<\/i><span>BAVA \u00b7 Nasdaq Copenhagen<\/span><em>Vaccines \u00b7 mpox, chikungunya<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>BioArctic<\/b><i>SE<\/i><span>BIOA B \u00b7 Nasdaq Stockholm<\/span><em>Alzheimer's \u00b7 Leqembi (Eisai)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>BioInvent<\/b><i>SE<\/i><span>BINV \u00b7 Nasdaq Stockholm<\/span><em>Oncology antibodies \u00b7 BI-1808, BI-1206<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>Camurus<\/b><i>SE<\/i><span>CAMX \u00b7 Nasdaq Stockholm<\/span><em>Long-acting injectables \u00b7 Buvidal\/Brixadi<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>Cinclus Pharma<\/b><i>SE<\/i><span>CINPHA \u00b7 Nasdaq Stockholm<\/span><em>Reflux disease \u00b7 linaprazan glurate<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>Egetis Therapeutics<\/b><i>SE<\/i><span>EGTX \u00b7 Nasdaq Stockholm<\/span><em>Rare diseases \u00b7 Emcitate (tiratricol)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Finland\"><b>Faron Pharmaceuticals<\/b><i>FI<\/i><span>FARON \u00b7 First North Finland \/ FARN \u00b7 AIM<\/span><em>Oncology \u00b7 bexmarilimab<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Denmark\"><b>Genmab<\/b><i>DK<\/i><span>GMAB \u00b7 Nasdaq Copenhagen, Nasdaq<\/span><em>Oncology antibodies \u00b7 Epkinly<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Denmark\"><b>Gubra<\/b><i>DK<\/i><span>GUBRA \u00b7 Nasdaq Copenhagen<\/span><em>Obesity \u00b7 peptide drugs (AbbVie)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>Hansa Biopharma<\/b><i>SE<\/i><span>HNSA \u00b7 Nasdaq Stockholm<\/span><em>Transplantation \u00b7 imlifidase<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden Swedish Orphan Biovitrum\"><b>Sobi<small>Swedish Orphan Biovitrum<\/small><\/b><i>SE<\/i><span>SOBI \u00b7 Nasdaq Stockholm<\/span><em>Rare diseases \u00b7 haematology, immunology<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Sweden\"><b>Vicore Pharma<\/b><i>SE<\/i><span>VICO \u00b7 Nasdaq Stockholm \/ VCRE \u00b7 Nasdaq<\/span><em>IPF \u00b7 buloxibutid<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Denmark\"><b>Zealand Pharma<\/b><i>DK<\/i><span>ZEAL \u00b7 Nasdaq Copenhagen<\/span><em>Obesity \u00b7 petrelintide (with Roche)<\/em><\/li>\n<\/ul><\/div>\n<div class=\"r5-group\" data-group=\"ukie\"><h4>UK &amp; Ireland<span data-total=\"7\" data-sub=\"\">7 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"United Kingdom\"><b>Autolus Therapeutics<\/b><i>UK<\/i><span>AUTL \u00b7 Nasdaq<\/span><em>Cell therapy \u00b7 Aucatzyl (obe-cel)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"United Kingdom\"><b>Bicycle Therapeutics<\/b><i>UK<\/i><span>BCYC \u00b7 Nasdaq<\/span><em>Oncology \u00b7 Bicycle drug conjugates<\/em><\/li>\n<li class=\"r5-co\" data-k=\"United Kingdom\"><b>Compass Pathways<\/b><i>UK<\/i><span>CMPS \u00b7 Nasdaq<\/span><em>Depression \u00b7 COMP360 psilocybin<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Ireland\"><b>GH Research<\/b><i>IE<\/i><span>GHRS \u00b7 Nasdaq<\/span><em>Depression \u00b7 GH001 (mebufotenin)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"United Kingdom\"><b>Immunocore<\/b><i>UK<\/i><span>IMCR \u00b7 Nasdaq<\/span><em>Oncology \u00b7 Kimmtrak, TCR bispecifics<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Ireland\"><b>Prothena<\/b><i>IE<\/i><span>PRTA \u00b7 Nasdaq<\/span><em>Neurodegeneration \u00b7 partnered antibodies<\/em><\/li>\n<li class=\"r5-co\" data-k=\"United Kingdom\"><b>Silence Therapeutics<\/b><i>UK<\/i><span>SLN \u00b7 Nasdaq<\/span><em>siRNA \u00b7 divesiran, zerlasiran<\/em><\/li>\n<\/ul><\/div>\n<div class=\"r5-group\" data-group=\"south\"><h4>Southern &amp; Eastern Europe<span data-total=\"5\" data-sub=\"\">5 companies<\/span><\/h4><ul class=\"r5-grid\">\n<li class=\"r5-co\" data-k=\"Poland\"><b>Molecure<\/b><i>PL<\/i><span>MOC \u00b7 Warsaw<\/span><em>Inflammation &amp; fibrosis \u00b7 OATD-01<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Spain\"><b>Oryzon Genomics<\/b><i>ES<\/i><span>ORY \u00b7 BME<\/span><em>Epigenetics \u00b7 iadademstat, vafidemstat<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Spain\"><b>PharmaMar<\/b><i>ES<\/i><span>PHM \u00b7 BME<\/span><em>Oncology \u00b7 Zepzelca (lurbinectedin)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Italy\"><b>Philogen<\/b><i>IT<\/i><span>PHIL \u00b7 Euronext Milan<\/span><em>Oncology \u00b7 Nidlegy (antibody-cytokine)<\/em><\/li>\n<li class=\"r5-co\" data-k=\"Poland\"><b>Ryvu Therapeutics<\/b><i>PL<\/i><span>RVU \u00b7 Warsaw<\/span><em>Oncology \u00b7 romaciclib<\/em><\/li>\n<\/ul><\/div>\n<p class=\"r5-empty\" hidden>No company matches your search. Missing one? <a href=\"\/contact\/\">Let us know<\/a>.<\/p>\n<p class=\"r5-note\">A selection of the listed companies we follow, as of October 2026. Country shows where the company is headquartered. Inclusion is not a recommendation, and does not imply any relationship between 5mn and the company.<\/p>\n<\/div>\n<script>\n(function(){\n  var roots=document.querySelectorAll('.r5');\n  for(var r=0;r<roots.length;r++) roots[r].classList.add('r5-js');\n  var chips=document.querySelectorAll('.r5 .r5-chip'), box=document.querySelector('.r5 .r5-search'),\n      groups=document.querySelectorAll('.r5 .r5-group'), empty=document.querySelector('.r5 .r5-empty'), active='all';\n  if(!box||!empty) return;\n  function norm(s){return (s||'').toLowerCase().normalize('NFD').replace(\/[\\u0300-\\u036f]\/g,'');}\n  function apply(){\n    var term=norm(box.value.trim()), total=0;\n    for(var i=0;i<groups.length;i++){\n      var g=groups[i], on=(active==='all'||g.getAttribute('data-group')===active), n=0,\n          cos=g.querySelectorAll('.r5-co');\n      for(var j=0;j<cos.length;j++){\n        var c=cos[j], ok=on&&(!term||norm(c.textContent+' '+c.getAttribute('data-k')).indexOf(term)>-1);\n        c.hidden=!ok; if(ok) n++;\n      }\n      g.hidden=(n===0); total+=n;\n      var lab=g.querySelector('h4 span'), all=+lab.getAttribute('data-total'), sub=lab.getAttribute('data-sub');\n      lab.textContent=(n<all? n+' of '+all : all)+' companies'+(sub? ' \u00b7 '+sub : '');\n    }\n    empty.hidden=(total>0);\n  }\n  for(var k=0;k<chips.length;k++){\n    chips[k].addEventListener('click',function(){\n      active=this.getAttribute('data-f');\n      for(var m=0;m<chips.length;m++) chips[m].setAttribute('aria-pressed', chips[m]===this?'true':'false');\n      apply();\n    });\n  }\n  box.addEventListener('input',apply);\n})();\n<\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>5mn Research \u00b7 Coming soon Our first Spotlights are on their way Spotlights are condensed, independent research on listed Swiss and European biotech companies, each with its own valuation model. While we prepare the first ones, here are the companies we follow. Investors and companies are welcome to get in touch: to hear when the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-769","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Research - 5mn<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research - 5mn\" \/>\n<meta property=\"og:description\" content=\"5mn Research \u00b7 Coming soon Our first Spotlights are on their way Spotlights are condensed, independent research on listed Swiss and European biotech companies, each with its own valuation model. While we prepare the first ones, here are the companies we follow. Investors and companies are welcome to get in touch: to hear when the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/5mn.ch\/de\/research\/\" \/>\n<meta property=\"og:site_name\" content=\"5mn\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-07T12:11:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/5mn.ch\\\/research\\\/\",\"url\":\"http:\\\/\\\/5mn.ch\\\/research\\\/\",\"name\":\"Research - 5mn\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/5mn.ch\\\/#website\"},\"datePublished\":\"2026-09-21T18:57:32+00:00\",\"dateModified\":\"2026-10-07T12:11:30+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/5mn.ch\\\/research\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/5mn.ch\\\/research\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/5mn.ch\\\/research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/5mn.ch\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/5mn.ch\\\/#website\",\"url\":\"https:\\\/\\\/5mn.ch\\\/\",\"name\":\"5mn\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/5mn.ch\\\/#organization\"},\"alternateName\":\"5mn.ch\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/5mn.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/5mn.ch\\\/#organization\",\"name\":\"5mn\",\"alternateName\":\"5mn.ch\",\"url\":\"https:\\\/\\\/5mn.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/5mn.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/5mn.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/5mn-icon-512_1.png\",\"contentUrl\":\"https:\\\/\\\/5mn.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/5mn-icon-512_1.png\",\"width\":512,\"height\":512,\"caption\":\"5mn\"},\"image\":{\"@id\":\"https:\\\/\\\/5mn.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research - 5mn","robots":{"index":"noindex","follow":"follow"},"og_locale":"de_DE","og_type":"article","og_title":"Research - 5mn","og_description":"5mn Research \u00b7 Coming soon Our first Spotlights are on their way Spotlights are condensed, independent research on listed Swiss and European biotech companies, each with its own valuation model. While we prepare the first ones, here are the companies we follow. Investors and companies are welcome to get in touch: to hear when the [&hellip;]","og_url":"http:\/\/5mn.ch\/de\/research\/","og_site_name":"5mn","article_modified_time":"2026-10-07T12:11:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/5mn.ch\/research\/","url":"http:\/\/5mn.ch\/research\/","name":"Research - 5mn","isPartOf":{"@id":"https:\/\/5mn.ch\/#website"},"datePublished":"2026-09-21T18:57:32+00:00","dateModified":"2026-10-07T12:11:30+00:00","breadcrumb":{"@id":"http:\/\/5mn.ch\/research\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["http:\/\/5mn.ch\/research\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/5mn.ch\/research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/5mn.ch\/"},{"@type":"ListItem","position":2,"name":"Research"}]},{"@type":"WebSite","@id":"https:\/\/5mn.ch\/#website","url":"https:\/\/5mn.ch\/","name":"5mn","description":"","publisher":{"@id":"https:\/\/5mn.ch\/#organization"},"alternateName":"5mn.ch","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/5mn.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/5mn.ch\/#organization","name":"5mn","alternateName":"5mn.ch","url":"https:\/\/5mn.ch\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/5mn.ch\/#\/schema\/logo\/image\/","url":"https:\/\/5mn.ch\/wp-content\/uploads\/2026\/10\/5mn-icon-512_1.png","contentUrl":"https:\/\/5mn.ch\/wp-content\/uploads\/2026\/10\/5mn-icon-512_1.png","width":512,"height":512,"caption":"5mn"},"image":{"@id":"https:\/\/5mn.ch\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/pages\/769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/comments?post=769"}],"version-history":[{"count":19,"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/pages\/769\/revisions"}],"predecessor-version":[{"id":1408,"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/pages\/769\/revisions\/1408"}],"wp:attachment":[{"href":"http:\/\/5mn.ch\/de\/wp-json\/wp\/v2\/media?parent=769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}